ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) — all Canadian products
32 DINs
24 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02339102 | APO-ESOMEPRAZOLE | APOTEX INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02339099 | APO-ESOMEPRAZOLE | APOTEX INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02560194 | APO-ESOMEPRAZOLE DELAYED-RELEASE | APOTEX INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Approved | |
| 02560186 | APO-ESOMEPRAZOLE DELAYED-RELEASE | APOTEX INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Approved | |
| 02442507 | ESOMEPRAZOLE | SIVEM PHARMACEUTICALS ULC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02520702 | ESOMEPRAZOLE | JAMP PHARMA CORPORATION | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02394839 | ESOMEPRAZOLE | PRO DOC LIMITEE | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02394847 | ESOMEPRAZOLE | PRO DOC LIMITEE | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02520699 | ESOMEPRAZOLE | JAMP PHARMA CORPORATION | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02442493 | ESOMEPRAZOLE | SIVEM PHARMACEUTICALS ULC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02520117 | M-ESOMEPRAZOLE | MANTRA PHARMA INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02520109 | M-ESOMEPRAZOLE | MANTRA PHARMA INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02479427 | MYL-ESOMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02479419 | MYL-ESOMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02300524 | NEXIUM | ASTRAZENECA CANADA INC | Granules For Suspension (Delayed-Release | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 10 MG | Marketed | |
| 02244521 | NEXIUM - 20MG | ASTRAZENECA CANADA INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02244522 | NEXIUM - 40MG | ASTRAZENECA CANADA INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02444712 | NEXIUM 24HR | HALEON CANADA ULC | Capsule (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02568322 | PRO-ESOMEPRAZOLE | PRO DOC LIMITEE | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Approved | |
| 02568314 | PRO-ESOMEPRAZOLE | PRO DOC LIMITEE | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Approved | |
| 02557673 | RIVA-ESOMEPRAZOLE | LABORATOIRE RIVA INC. | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02557681 | RIVA-ESOMEPRAZOLE | LABORATOIRE RIVA INC. | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02423987 | TARO-ESOMEPRAZOLE | SUN PHARMA CANADA INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Marketed | |
| 02423979 | TARO-ESOMEPRAZOLE | SUN PHARMA CANADA INC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02438488 | ESOMEPRAZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Cancelled Pre Market | |
| 02449587 | ESOMEPRAZOLE | TEVA CANADA LIMITED | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Cancelled Pre Market | |
| 02449595 | ESOMEPRAZOLE | TEVA CANADA LIMITED | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Cancelled Pre Market | |
| 02438461 | ESOMEPRAZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Cancelled Pre Market | |
| 02383039 | MYLAN-ESOMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Cancelled Post Market | |
| 02383047 | MYLAN-ESOMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Cancelled Post Market | |
| 02414392 | MYLAN-ESOMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Capsule (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Cancelled Pre Market | |
| 02414406 | MYLAN-ESOMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Capsule (Delayed-Release) | Oral | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 40 MG | Cancelled Pre Market |
Browse other molecules: